Public Policy Resources

Share

As a recognized expert in cancer health policy, ACS CAN develops reports, white papers, testimony, fact sheets, regulatory comment letters and public policy on a wide range of issues related to preventing cancer and improving the health care system for persons with cancer and survivors.  We encourage you to use this resource to learn more about our issue priorities and policy work. If you can't find something you need, you may contact us by using our contact form and selecting Policy Resources from the drop-down menu.

Search for Resources

FILTER BY:

Woman seeing her physician

Access to Health Care

ACS CAN advocates for policies that provide access to treatments and services people with cancer need for their care - including those who may be newly diagnosed, in active treatment and cancer survivors.

ACS CAN Comments on Notice of Benefit and Payment Parameters proposed rule for plan year 2027

March 13, 2026

On Friday, March 13, 2026, ACS CAN filed comments in response to the Notice of Benefit and Payment Parameters proposed rule for plan year 2027. 

We offered comments on the following proposals:

ACS & ACS CAN Comment Letter to ACIP for March 2026 Meeting

March 11, 2026

The American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN) are pleased to provide comments to the Advisory Committee on Immunization Practices (ACIP). Our comments reflect our commitment to cancer prevention and control and focus on ensuring that the Centers for Disease Control and Prevention’s (CDC) immunization schedules are grounded in strong scientific evidence, and provide clear, actionable information to healthcare professionals, parents, and payers.

ACS CAN Comments on Global Benchmark for Efficient Drug Pricing (GLOBE) Model proposed rule

February 24, 2026

ACS CAN filed a comment letter regarding the policies included in the Global Benchmark for Efficient Drug Pricing (GLOBE) Model proposed rule.

View All Access to Health Care Resources

Photo of ACS CAN Volunteers at Advocacy Event to Support Cancer Research Funding

Research, Funding and Drug Development

Improvements in outcomes for cancer patients require continued research and innovation.  ACS CAN advocates for robust federal funding for cancer research, as well as research and drug approval policies that accelerate the development of new treatments while still ensuring patient safety.

Overwhelming Majority of Cancer Patients and Survivors Support Broad Community Immunization and Oppose Limiting Access to Vaccines

February 18, 2026

Our latest Survivor Views survey underscores the critical role of evidence-based vaccinations in promoting public health and protecting communities impacted by cancer. Cancer patients and survivors overwhelmingly agree on the importance of community immunization, oppose limits to vaccine access, and support school entry requirements. In addition, the survey finds strong support for investment in the oncology potential of vaccines.

ACS CAN Response to RFI on Accelerating the Adoption and Use of Artificial Intelligence as Part of Clinical Care

February 17, 2026

ACS CAN submitted a response to the December 2025 Request for Information on Accelerating the Adoption and Use of Artificial Intelligence as Part of Clinical Care. 

ACS CAN joined by 24 groups in support of AKS safe harbor allowing financial support to trial participants

February 9, 2026

Twenty five groups joined to ask the HHS Office of Inspector General (OIG) to create a safe harbor from the Anti-Kickback Statute (AKS) allowing sponsors to financially support participants in cancer clinical trials. 

View All Research, Funding and Drug Development Resources

Photo of Making Strides Against Breast Cancer Event Participant

Prevention and Early Detection

ACS CAN advocates for public policies that can prevent nearly half of all cancer deaths by ensuring access to recommended cancer screenings, protecting the public from skin cancer risk, reducing tobacco use and exposure to secondhand smoke and supporting people in increasing physical activity, eating a healthy diet, and managing their weight.

ACS CAN comments on NCQA colorectal cancer screening HEDIS measure

March 12, 2026

The American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN) submitted comments to the National Committee for Quality Assurance’s (NCQA’s) on their proposed new quality measure for HEDIS measurement year (MY) 2027 related to follow-up after positive colorectal

ACS & ACS CAN Comment Letter to ACIP for March 2026 Meeting

March 11, 2026

The American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN) are pleased to provide comments to the Advisory Committee on Immunization Practices (ACIP). Our comments reflect our commitment to cancer prevention and control and focus on ensuring that the Centers for Disease Control and Prevention’s (CDC) immunization schedules are grounded in strong scientific evidence, and provide clear, actionable information to healthcare professionals, parents, and payers.

Food is Medicine Initiatives to Address Cancer & Chronic Diseases

March 10, 2026

The American Cancer Society Cancer Action Network (ACS CAN) supports policies and funding that increase access to “Food is Medicine” (or food as medicine) initiatives and interventions intended to prevent, treat, or manage chronic diseases and often address food and nutrition insecurity.

View All Prevention and Early Detection Resources

Doctor and Patient

Health Equity

ACS CAN supports health equity efforts for all Americans so they may receive access to quality care, no matter their race, ethnicity, sexual orientation, income level or ZIP code. 

Increasing Access to Cancer Screenings for Individuals with Disabilities

September 30, 2025

For the American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN), health equity means that everyone has a fair and just opportunity to prevent, detect, treat, and survive cancer – no matter how much money someone makes, the color of their skin, sexual orientat

Solo los datos: Desigualdades en el cáncer de seno

May 29, 2025

El cáncer de seno es el tipo de cáncer que se diagnostica con mayor frecuencia en mujeres en EE.UU. Aunque en lasúltimas décadas se han logrado avances sustanciales en la reducción de la mortalidad por esta enfermedad,persisten desigualdades, especialmente entre las mujeres de raza negra.

ACS, ACS CAN and Partners Joint Comments on Patient Navigation Provisions of CY2025 Medicare Physician Fee Schedule Proposed Rule

September 9, 2024

The American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN) along with partners appreciate the opportunity to comment on the Patient Navigation provisions of CY2025 Medicare Physician Fee Schedule.

View All Health Equity Resources